Advent Bioservices moves in at Cadence building on Unity Campus

Advent Bioservices has committed to a 5+5-year lease of lab and office space within the Cadence building at Unity Campus, further strengthening South Cambridge’s growing bioscience cluster.

The addition of Advent Bioservices means that, following practical completion in May, 87 per cent of Phase 2 at the Howard Group-owned campus will be let.

Katherine Friend, director – investment and asset management, Howard Group, said: "We are thrilled to welcome Advent Bioservices to Unity Campus.

“Their groundbreaking work in cell therapy aligns perfectly with our vision for Unity Campus as a hub for world-class innovation, breakthroughs, and collaboration in the life sciences sector and further reinforces Unity Campus’ position as a prime destination for pioneering research and development.

“We look forward to supporting their growth and success within our community."

Advent Bioservices began operations in 2016 and is based in Sawston. The company is a contract development and manufacturing organisation (CDMO) providing good manufacturing practice, manufacturing of advanced therapy medicinal products, and related products and services.

At the forefront of revolutionary medicine in which life-threatening diseases are treated using advanced therapy medicinal products, Advent Bioservices supports the development of complex, breakthrough therapies for a globally diverse market.

Mike Scott, president, Advent Bioservices, said: “We are delighted to be taking occupancy on Unity Campus. This space will permit Advent to expand and diversify process development, microbiological testing and quality assurance and quality control services to biotech and drug development companies working in the cell and gene therapy sector.”